New directions to develop therapies for people with hemophilia
Pooja Gogia(Memorial Sloan Kettering Cancer Center), Louis M. Aledort(Icahn School of Medicine at Mount Sinai), Michael D. Tarantino(Bleeding & Clotting Disorders Institute), Wolfgang Schramm(München Klinik)
Cited by 23
Related Papers
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Definitions in Hemophilia
|Thrombosis and Haemostasis|2001|772
A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacs
|Journal of Internal Medicine|1994|613
A More Uniform Measurement of Factor VIII Inhibitors
|Thrombosis and Haemostasis|1975|587